Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02990455 · ClinicalTrials.gov registry record · Phase 1
Reduced Nicotine Cigarettes in Smokers With and Without Alcohol Use Disorder
A Phase 1 study, sponsored by Battelle Memorial Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 47
- Enrollment target
NCT02990455 is a Phase 1 study that has completed, run by Battelle Memorial Institute. The registered enrollment target is 47 participants.
The verdict
NCT02990455, a Phase 1 study, has completed, sponsored by Battelle Memorial Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 47 participants
- Enrollment target
Study Summary
The proposed research will investigate whether smokers with vs. without current at-risk alcohol drinking (ARD) respond to reduced nicotine cigarettes by increasing their alcohol consumption or smoke exposure, thereby diminishing the hypothesized public health benefit of these new products.
Interventions
- DRUG Reduced nicotine cigarettes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2017-11-14 |
| Est. Completion | 2021-04-21 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02990455
The ClinicalTrials.gov registry entry for NCT02990455 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Battelle Memorial Institute, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reduced nicotine cigarettes is the first listed.
NCT02990455 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02990455 about?
NCT02990455 is a clinical study titled "Reduced Nicotine Cigarettes in Smokers With and Without Alcohol Use Disorder". The proposed research will investigate whether smokers with vs. without current at-risk alcohol drinking (ARD) respond to reduced nicotine cigarettes by increasing their alcohol consumption or smoke exposure, thereby diminishing the hypothesized public health benefit of these new products.
What is the current status of trial NCT02990455?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 47 participants. The study started on 2017-11-14. Estimated completion is 2021-04-21.
What interventions are being tested in trial NCT02990455?
The interventions under investigation include: Reduced nicotine cigarettes (DRUG).
Who is sponsoring clinical trial NCT02990455?
This trial is sponsored by Battelle Memorial Institute, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.